Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

avatar
101870990 Private ID: 101870990
No profile added yet
Follow
    101870990 commented on
    14
    Recently, metaverse has become the hottest topic to which mooers are paying close attention. Standing on the cusp of virtual social networking, social media giant Facebook has changed its name to lead the latest trend. $Meta Platforms(FB.US)$ Events are happening every day in moomoo. Which trends are mooers riding?
    To embrace the new trend, @moomoo Academy is changing its name. We are still committed to sharing the most advanced investment ideas and knowledge, launching activities to gather your views, and posting the outstanding ones in the account for all of you. Here is where mooers' wisdom is accumulated, and gamification strategies are adopted to make teaching more engaging!
    Let's get together to brainstorm and choose a new trending name for @moomoo Academy. Here, we have three proposals:
    1. Meta Moo
    Learning is like playing a game where you work hard to defeat the monsters to get to the higher levels. Intuition developed from the past investing experience becomes a vital part of an investor's toolkit. Immerse yourself in moomoo and explore the virtual gamification elements of social interaction.
    2. moomoo Idea
    Collect every idea you have when you are investing, and finally, construct your unique investment logic. Here, we are presenting the investment insights shared by you, our dear friends.
    3. mooers Strategy
    Share your investment strategies and experiences with all mooers so that beginners can learn from the experienced and mooers can interact with their counterparts. You are improving as you are communicating.
    Hunting moment! Cast your precious vote in the name-changing survey of @moomoo Academy.
    We are calling on mooers to be part of the name changing event and become the content producers of the new account. Name changing is so cool, and we want you to be part of it. Please remember that all suggestions are welcome and appreciated.
    If you have a better name, please leave it in the comment below!
    33
    101870990 reacted to
    A recent study shows that Singapore's Generation Z investors grew by 90% year-on-year in the second quarter of 2021, and their investment assets became eightfold. (i.e. stocks, futures, and options)
    As the global epidemic results in an overflow of liquidity, and liquidity incentives investors run into the market. Among them, Gen Z investors have more passion and courage to take a chance.
    What do you want to say to Gen Z investors? Are Gen Z investors running too fast? Or it's just a beginning of a new era?
    Reward:
    Click "Enter Now" and leave your comment before Oct 29 to win 66 points!(more than 20 words to qualify)
    Up 90% in a year: SG's Gen Z investors are running into the market
    7
    SG stocks are slow moving. After dividend,  price dropped alot, cannot sustain the losses. Regretted investing in SG stocks. The only profitable uptrend will be Nikko AM STI or STI ETF.
    $AbCellera Biologics(ABCL.US)$ Market cap of $5.5 billion, up 15% premarket.
    101870990 reacted to
    The full FDA approval of Pfizer-BioNTech COVID-19 vaccine for age 16 and above is likely to give a boost to investors’ confidence in $Pfizer(PFE.US)$ and $BioNTech(BNTX.US)$ as it can lead to more people taking the vaccine. Pfizer-BioNTech enjoys a first mover advantage as its MRNA vaccine was the first to be issued EUA by FDA. With booster shots being advocated and more companies requiring their employees to be vaccinated, it can only mean more revenue.
    Moderna is close behind as the second vaccine to receive the EUA from FDA. It has just completed submission to FDA tor full approval of the vaccine for age 18 and older. The stock price of $Moderna(MRNA.US)$ has rallied a lot recently due to it joining S&P 500 $SPDR S&P 500 ETF(SPY.US)$ so it remains to be seen whether it can still make new highs.
    For the other vaccine stocks, the prospects may be less clear. As more countries try to develop their own local vaccines, the competition will become stiffer and the number of potential buyers may decrease.
    The Oxford vaccine licensed by $AstraZeneca(AZN.US)$ has been mired in a number of controversies and it has yet to receive EUA from the FDA. There is word the company is reviewing the long term sustainability of the COVID-19 vaccine business.
    $Novavax(NVAX.US)$ has received much interest in its non-MRNA vaccine but until it is rolled out, there may still be unknowns with regards to its performance and safety.
    Last but not least, it is important to note that pharmaceutical business goes beyond the COVID-19 vaccine so the stock price can be affected by non-vaccine related developments.
    Disclaimer: The above is not financial advice and should not be taken as a recommendation to invest. Please do your due diligence and consult your financial adviser before making any investment decision.
    If you enjoy reading this article, you may also be interested in
    “California Streaming” and Aapl’s Short Term Outlook https://www.moomoo.com/en-sg/community/feed/106924953829382?lang_code=2
    Highest Returns To Date https://www.moomoo.com/en-sg/community/feed/106911175344134?lang_code=2
    Great CEOs: Tim Cook and Steve Jobs https://www.moomoo.com/en-sg/community/feed/106837029355526?lang_code=2
    My Opinion on Vaccine Stocks
    My Opinion on Vaccine Stocks
    16
No more